Guided Therapeutics (GTHP) Other Non Operating Income (2013 - 2025)
Guided Therapeutics recorded quarterly Other Non Operating Income of -$579000.0 in Q4 2025, down 1464.86% quarter-over-quarter from -$37000.0 in Q3 2025, and down 5690.0% year-over-year from $10357.8 in Q4 2024.
Guided Therapeutics' Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$579000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income fell 5690.0% year-over-year to -$579000.0; the TTM figure through Dec 2025 stood at -$518000.0 (down 3137.5% YoY), while the FY2025 annual figure was -$533000.0, down 2861.11% from the prior year.
- Other Non Operating Income came in at -$579000.0 for Q4 2025 at Guided Therapeutics, down from -$37000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $763000.0 in Q3 2021 to a low of -$579000.0 in Q4 2025.
- A 5-year average of $9352.9 and a median of $1000.0 in 2022 frame the typical range for Other Non Operating Income.
- On a YoY basis, Other Non Operating Income climbed as much as 9700.0% in 2025 and fell as far as 5690.0% in 2025.
- Guided Therapeutics' Other Non Operating Income stood at $537000.0 in 2021, then slumped by 97.95% to $11000.0 in 2022, then slumped by 372.73% to -$30000.0 in 2023, then surged by 66.67% to -$10000.0 in 2024, then sank by 5690.0% to -$579000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$579000.0, -$37000.0, and $98000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -579,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -64,000.00 |
| Dec 31, 2021 | 537,000.00 |
| Sep 30, 2021 | 763,000.00 |
| Jun 30, 2021 | -473,000.00 |
| Mar 31, 2021 | -88,000.00 |
| Dec 31, 2020 | 3.56 Mn |
| Sep 30, 2020 | 1.73 Mn |
| Jun 30, 2020 | -5.78 Mn |
| Mar 31, 2020 | 28,000.00 |
| Sep 30, 2019 | 412,000.00 |
| Jun 30, 2019 | -2.34 Mn |
| Mar 31, 2019 | 409,000.00 |
| Dec 31, 2018 | -840,000.00 |
| Sep 30, 2018 | 1.04 Mn |
| Jun 30, 2018 | 4.20 Mn |
| Mar 31, 2018 | 1.69 Mn |
| Dec 31, 2017 | -4.03 Mn |
| Sep 30, 2017 | -1.03 Mn |
| Jun 30, 2017 | -226,000.00 |
| Mar 31, 2017 | 628,000.00 |
| Dec 31, 2016 | 931,000.00 |
| Sep 30, 2016 | 670,000.00 |
| Jun 30, 2016 | 211,000.00 |
| Mar 31, 2016 | 1.40 Mn |
| Dec 31, 2015 | -214,000.00 |
| Sep 30, 2015 | -353,000.00 |
| Jun 30, 2015 | -66,000.00 |
| Mar 31, 2015 | 714,000.00 |
| Dec 31, 2014 | 230,000.00 |
| Sep 30, 2014 | -557,000.00 |
| Jun 30, 2014 | -125,000.00 |
| Mar 31, 2014 | 542,000.00 |
| Dec 31, 2013 | -674,000.00 |